Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!

Greetings from Chicago, where once again, immunotherapy remains the highlight of most ASCO presentations.  This year was particularly exciting, as we finally got to see the preliminary results of the first clinical trials of checkpoint inhibitors for sarcomas.  So, I will update all of you on the most recent data, explain how we still have more … More Updates from ASCO 2016: Immunotherapy for sarcoma shows a signal!

Clinical Trials: What you should know to make an informed choice about your therapy.

This is a guinea pig. Greetings readers, My 282 page grant finally went in Monday – and so now I finally have some spare writing quota to return to the blog!  Today’s topic – everything you ever needed to know about clinical trials.  The goal is to clear up some misconceptions, and also to help … More Clinical Trials: What you should know to make an informed choice about your therapy.

have we really reached the era of personalized medicine?

Borrowed from Chakma J. Genomic Variation: The Search for our Past and Our Future.  Journal of Young Investigators. Vol 16, 2009. The White House Initiative The concept of personalized medicine has received a tremendous amount of media attention as of late, and in this post I thought I would try to outline the various technologies, concepts, … More have we really reached the era of personalized medicine?

Immunotherapy 101

In honor of the 4th of July holiday, I thought I’d squeeze in one more post – let’s talk about IMMUNOTHERAPY, which has created fireworks of its own in the cancer treatment world! In order to talk about the exciting clinical trials and ideas that are out there for sarcoma patients, we need to first … More Immunotherapy 101

why sarcoma?

A lot of people ask me why I take care of sarcoma patients – no one knows what they are (except for all of you kind readers who are now experts!), there’s no good data, certainly no major funding opportunities, and we’re still using the same chemotherapy drugs that we have used since 1970s… not … More why sarcoma?